Emergent BioSolutions Secures Contract Modification Valued at Approximately $52.7 Million for ACAM2000® (Smallpox and Mpox (Vaccinia) Vaccine, Live) from the U.S. Government
Go back to Emergent BioSolutions Secures Contract Modification Valued at Approximately $52.7 Million for ACAM2000® (Smallpox and Mpox (Vaccinia) Vaccine, Live) from the U.S. Government| EMERGENT BIOSOLUTIONS, Inc. (NYSE: EBS) | Delayed: 7.26 -0.24 (3.2%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.50 | 52 Week High | $44.38 | |||
| Open | $7.51 | 52 Week Low | $24.47 | |||
| Day High | $7.65 | P/E | 363.00 | |||
| Day Low | $7.24 | EPS | $0.02 | |||
| Volume | 554,005 | |||||
